EML4 and lung adenocarcinoma: [81] further emphasized the importance of multi‐lesion profiling in a case of synchronous bilateral lung adenocarcinomas, revealing spatially distinct drivers—EML4‐ALK in the right lobe and TPM3‐ROS1 in the left—confirmed as independent primaries by genomic analysis.